TISCO: Biotech Profits to Rise 19.5% in '69, Healthcare Stocks Recommended

Prachachat•Economy•9h ago

Reader Briefing

TISCO forecasts strong profit growth for the biotechnology sector within the healthcare industry, driven by global demographic shifts towards an aging population.

•TISCO recommends investing in four sub-sectors of the healthcare industry, particularly Biotechnology and Medical Devices.
•The global population is rapidly aging, with significant increases predicted for those aged 60+ and 80+ in the coming decades.
•Global healthcare spending is projected to rise, making the healthcare sector a 'Defensive Growth' investment opportunity.
•Biotechnology is expected to lead profit growth with an estimated 19.5% EPS increase in 2026, supported by innovation and M&A potential.
•Medical Devices and Equipment are also projected for healthy growth, benefiting from AI applications and cost reductions due to lower interest rates.

Overview

•The world is rapidly transitioning into an aging society, with the WHO projecting significant growth in the 60+ population by 2030 and beyond.
•The number of individuals aged 60 and over is projected to increase from 1 billion in 2015 to 1.4 billion by 2030, and double to 2.1 billion by 2050.
•The population aged 80 and over is expected to triple between 2015 and 2050, reaching approximately 426 million.
•Global healthcare spending is anticipated to increase by about 10% in 2026, according to WTW (Willis Towers Watson).
•The healthcare sector is identified as 'Defensive Growth' due to its resilience against economic downturns and long-term structural growth drivers.
•Biotechnology is predicted to achieve the highest EPS Growth in 2026 at approximately 19.5%, with additional support from potential M&A activities.
•Medical Devices & Equipment (MedTech) are projected to see EPS growth of around 6% in 2026, driven by AI integration.
•TISCO's investment strategy for 2026 emphasizes an overweight position in Biotech and MedTech to capture profit growth and structural catalysts.

Full article content is available on the original source.

Read on Prachachat (Thai Version)View in Google Translate

Source: Prachachat (Original)

Key Quotes

Natthakrit Laotaweesap

"As the world rapidly enters an aging society, the World Health Organization (WHO) estimates that by 2030, one in six people globally will be over 60 years old."

ขณะที่โลกกำลังก้าวเข้าสู่สังคมสูงวัยอย่างรวดเร็ว องค์การอนามัยโลก (WHO) คาดว่า ภายในปี 2030 ประชากรโลก 1 ใน 6 จะมีอายุ 60 ปีขึ้นไป

Anonymous Analyst

"Healthcare is seen as 'Defensive Growth,' resilient to economic downturns due to demand that is relatively inelastic to economic cycles."

Healthcare จึงถูกมองเป็น “Defensive Growth” คือ มีความทนทานต่อภาวะเศรษฐกิจถดถอยจากความต้องการที่ค่อนข้างยืดหยุ่นต่อวัฏจักรเศรษฐกิจ

Anonymous Analyst

"Biotechnology is expected to show the most outstanding EPS Growth in 2026 at approximately 19.5%, aligning with its high-growth business nature."

Biotechnology มีแนวโน้ม EPS Growth โดดเด่นที่สุดในปี 2026 ที่ประมาณ 19.5% สอดคล้องกับลักษณะธุรกิจที่เติบโตสูง

Key Entities

Organization

TISCO(ทิสโก้)ℹ️

Financial institution that predicted profit growth for the Biotechnology sector and recommended healthcare stocks.

Biotechnology(ไบโอเทค)ℹ️

A sector within the healthcare industry expected to experience significant profit growth.

Healthcare(เฮลธ์แคร์)ℹ️

A broad industry sector recommended for investment due to demographic trends and growth potential.

World Health Organization (WHO)(องค์การอนามัยโลก)ℹ️

International organization that provided demographic projections related to an aging global population.

WTW (Willis Towers Watson)(WTW)ℹ️

An institution that forecast global healthcare spending growth.

BridgeBio Pharmaℹ️

A company mentioned as an example of successful stock performance after receiving FDA approval for a rare heart disease drug.

REVOLUTION Medicinesℹ️

A company whose cancer drug trial showed positive results, making it a potential acquisition target and leading to stock price increases.

Person

Nathtakrit Laotaweesap(นายณัฐกฤติ เหล่าทวีทรัพย์)

Head of Wealth Advisory at TISCO Bank, who provided insights on the healthcare sector.

Timeline

202569(ปี 2026)

The projection year for significant profit growth in the biotechnology sector and healthcare spending.

2030(ปี 2030)

The year by which the WHO projects one in six people globally will be aged 60 and over.

2015(ปี 2020)

The year from which the number of people aged 60 and over was reported as 1 billion.

2050(ปี 2050)

The year by which the number of people aged 60 and over is projected to double, and the population aged 80 and over is projected to triple.

late 2024(ปลายปี 2024)

The period when BridgeBio Pharma received FDA approval for a drug.

2025(ปี 2025)

The year when BridgeBio Pharma experienced revenue growth beyond expectations and REVOLUTION Medicines' stock price began to rise.

January 2026(มกราคม 2026)

The end point for the period during which REVOLUTION Medicines' stock price increased by over 120%.